WRM
ALXN

Westport Resources Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Westport Resources Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-850
Closed -$8K – 868
2015
Q4 		$8K Sell
850
-50
-6% -$8.73K ﹤0.01% 745
2015
Q3 		$9K Sell
900
-60
-6% -$10.9K ﹤0.01% 750
2015
Q2 		$10K Sell
960
-150
-14% -$25.9K ﹤0.01% 752
2015
Q1 		$11K Sell
1,110
-40
-3% -$7.24K ﹤0.01% 791
2014
Q4 		$12K Hold
1,150
– – ﹤0.01% 815
2014
Q3 		$12K Hold
1,150
– – ﹤0.01% 814
2014
Q2 		$12K Hold
1,150
– – ﹤0.01% 844
2014
Q1 		$175K Hold
1,150
– – 0.05% 317
2013
Q4 		$153K Sell
1,150
-100
-8% -$12K 0.04% 328
2013
Q3 		$145K Buy
1,250
+200
+19% +$21.9K 0.05% 310
2013
Q2 		$97K Buy
+1,050
New +$101K 0.03% 365

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return